Category Archives: new treatments

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

Posted on October 15, 2012 by Maurice Preter MD

Good news. Time to start a proper curcumin trial. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults Yen Ying Lim, MPsych, Kathryn A. Ellis, PhD, Robert H. Pietrzak, PhD, MPH, David Ames, MD, … Continue reading →

Posted in Aging, dietary, epigenetics, Health, new treatments, News, Psychiatry/Neurology | Tagged healthy brain aging, Inflammation, Memory and Memory Loss |

Anti-inflammatory utility of Boswellia serrata (frankincense)

Posted on July 27, 2012 by Maurice Preter MD

Reading up on Boswellia serrata – this is a good starter article: http://www.altmedrev.com/publications/13/2/165.pdf “Boswellia serrata Description Boswellia serrata (frankincense) is a moderate-to-large branching tree (growing to a height of 12 feet) found in India, Northern Africa, and the Middle East. … Continue reading →

Posted in Aging, Health, new treatments | Tagged Depression, healthy brain aging, Inflammation, Memory and Memory Loss, Pain and Headache, Traumatic Brain Injury |

A role for vitamin D in the treatment of multiple sclerosis (MS)

Posted on July 26, 2012 by Maurice Preter MD

This is such an important topic that I am posting the full-length article. On pubmed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882221/?tool=pubmed. Neurology. 2010 June 8; 74(23): 1852–1859. doi: 10.1212/WNL.0b013e3181e1cec2 PMCID: PMC2882221 A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis … Continue reading →

Posted in dietary, Health, metabolic, new treatments, Psychiatry/Neurology | Tagged demyelinating disease, healthy brain aging, Inflammation, Memory and Memory Loss, multiple sclerosis |

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.

Posted on March 3, 2012 by Maurice Preter MD

Nutr J. 2011 Oct 20;10:117. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. … Continue reading →

Posted in Aging, Health, metabolic, new treatments | Tagged healthy brain aging, Inflammation, Memory and Memory Loss |

Category Archives: new treatments

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

Anti-inflammatory utility of Boswellia serrata (frankincense)

A role for vitamin D in the treatment of multiple sclerosis (MS)

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.

Maurice Preter, MD

QUICK LINKS

ADDRESS